0 Évaluations

ID

13997

Description

A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT01546038

Lien

https://clinicaltrials.gov/show/NCT01546038

Mots-clés

  1. 21/03/2016 21/03/2016 -
Téléchargé le

21 mars 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Acute Myeloid Leukemia NCT01546038

    Eligibility Acute Myeloid Leukemia NCT01546038

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    Patients with aml or raeb 2 high risk mds who are newly diagnosed according to the who 2008 classification and previously untreated.
    Description

    Acute Myelocytic Leukemia

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023467
    Patients with aml (arising from an antecedent hematologic disease [ahd]) or mds who may have had one prior regimen with commercially available agents for the treatment of their prior hematologic disease. the patients may not have had a prior therapy for their aml.
    Description

    MDS

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C3463824
    aml patients include de novo aml, aml evolving from mds or other ahd and aml after previous cytotoxic therapy or radiation (secondary aml)
    Description

    Therapy-related acute myeloid leukemia and myelodysplastic syndrome

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1292776
    For a diagnosis of aml, a bone marrow blast count of 20% or more is required.
    Description

    Leukemic Blast Count

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2697913
    For a diagnosis of high-risk myelodysplastic syndrome raeb 2 the patient must have 10-19% bone marrow blasts
    Description

    Bone marrow blasts

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1982687
    Adequate organ function
    Description

    Organ function

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1254358
    ecog performance status 0, 1, or 2
    Description

    ECOG

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    aml m3 acute promyelocytic leukemia (apl) or patients with a t(9:22) cytogenetic translocation.
    Description

    Acute Promyelocytic Leukemia

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023487
    patients with known active uncontrolled central nervous system (cns) leukemia.
    Description

    Central nervous system leukaemia

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1332884

    Similar models

    Eligibility Acute Myeloid Leukemia NCT01546038

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Acute Myelocytic Leukemia
    Item
    Patients with aml or raeb 2 high risk mds who are newly diagnosed according to the who 2008 classification and previously untreated.
    boolean
    C0023467 (UMLS CUI [1])
    MDS
    Item
    Patients with aml (arising from an antecedent hematologic disease [ahd]) or mds who may have had one prior regimen with commercially available agents for the treatment of their prior hematologic disease. the patients may not have had a prior therapy for their aml.
    boolean
    C3463824 (UMLS CUI [1])
    Therapy-related acute myeloid leukemia and myelodysplastic syndrome
    Item
    aml patients include de novo aml, aml evolving from mds or other ahd and aml after previous cytotoxic therapy or radiation (secondary aml)
    boolean
    C1292776 (UMLS CUI [1])
    Leukemic Blast Count
    Item
    For a diagnosis of aml, a bone marrow blast count of 20% or more is required.
    boolean
    C2697913 (UMLS CUI [1])
    Bone marrow blasts
    Item
    For a diagnosis of high-risk myelodysplastic syndrome raeb 2 the patient must have 10-19% bone marrow blasts
    boolean
    C1982687 (UMLS CUI [1])
    Organ function
    Item
    Adequate organ function
    boolean
    C1254358 (UMLS CUI [1])
    ECOG
    Item
    ecog performance status 0, 1, or 2
    boolean
    C1520224 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Acute Promyelocytic Leukemia
    Item
    aml m3 acute promyelocytic leukemia (apl) or patients with a t(9:22) cytogenetic translocation.
    boolean
    C0023487 (UMLS CUI [1])
    Central nervous system leukaemia
    Item
    patients with known active uncontrolled central nervous system (cns) leukemia.
    boolean
    C1332884 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial